Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Kramer

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pharmacoepidemiology and Drug Safety|January 11, 2005
Managing the risks of therapeutic products: proceedings of a workshopJudith M Kramer
The New England Journal of Medicine|April 17, 2009
Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of valuesJudith M Kramer
Pharmacoepidemiology and Drug Safety|July 26, 2008
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessmentRobert M Califf, Judith M Kramer
Pharmacotherapy|November 5, 2003
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptanceNancy M Allen LaPointe, Carol A Pamer, Judith M Kramer
Clinical Trials (London, England)|May 7, 2013
Participants' perspectives on safety monitoring in clinical trialsKathryn E Flynn, Judith M Kramer, Carrie B Dombeck, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug ApplicationPatrick Archdeacon, Cheryl Grandinetti, José M Vega, et al.
American Heart Journal|June 17, 2004
Part I: Identifying holes in the safety netJ Conor O'Shea, Judith M Kramer, Robert M Califf, et al.
Pharmacotherapy|August 14, 2002
Practitioner acceptance of the dofetilide risk-management programNancy M Allen LaPointe, Judith M Kramer, Kevin P Weinfurt, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Industry Practices for Expedited Reporting to Investigators Conducting Research Under an INDSundeep S Sethi, Judith M Kramer, Suzanne Gagnon, et al.
JAMA|February 27, 2009
Scientific evidence underlying the ACC/AHA clinical practice guidelinesPierluigi Tricoci, Joseph M Allen, Judith M Kramer, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|January 11, 2005
Managing the risks of therapeutic products: proceedings of a workshopJudith M Kramer
The New England Journal of Medicine|April 17, 2009
Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of valuesJudith M Kramer
Pharmacoepidemiology and Drug Safety|July 26, 2008
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessmentRobert M Califf, Judith M Kramer
Pharmacotherapy|November 5, 2003
New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptanceNancy M Allen LaPointe, Carol A Pamer, Judith M Kramer
Clinical Trials (London, England)|May 7, 2013
Participants' perspectives on safety monitoring in clinical trialsKathryn E Flynn, Judith M Kramer, Carrie B Dombeck, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug ApplicationPatrick Archdeacon, Cheryl Grandinetti, José M Vega, et al.
American Heart Journal|June 17, 2004
Part I: Identifying holes in the safety netJ Conor O'Shea, Judith M Kramer, Robert M Califf, et al.
Pharmacotherapy|August 14, 2002
Practitioner acceptance of the dofetilide risk-management programNancy M Allen LaPointe, Judith M Kramer, Kevin P Weinfurt, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Industry Practices for Expedited Reporting to Investigators Conducting Research Under an INDSundeep S Sethi, Judith M Kramer, Suzanne Gagnon, et al.
JAMA|February 27, 2009
Scientific evidence underlying the ACC/AHA clinical practice guidelinesPierluigi Tricoci, Joseph M Allen, Judith M Kramer, et al.
Pageof 5